Navigation Links
Vol in Medical Technology

Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer

...hase III randomized placebo-controlled Trial (SHARP trial), Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. vol 25, No. 18S (June 20 Supplement), 2007: LBA1 [2] Health Risks from Dioxin and Related Compounds, National Research Council, Natio...

AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds

...or Aurora B kinase. Aurora A and B have been shown to be over-expressed in a broad range of tumours. 4)Hung Huynh et al (2006),Clin Cancer Res;4309, vol 12 (14) July 15 ...

Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections

...2) Klevens, et al. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002. Public Health Reports, March-April 2007, vol 122, pp. 160-166. (3) Cardinal Health analysis of 3.1 million admissions across 100 hospitals, 2007. ...

Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds

... and strategic partners and other factors described in the Quest Diagnostics Incorporated 2007 Form 10-K and subsequent SEC filings. (1) THE LANCET, vol 361, March 1, 2003 (2) DIABETES CARE, VOLUME 31, NUMBER 4, APRIL 2008 ...

New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma

...utic as adjuvant therapy in stage IB/II Non-Small Cell Lung Cancer (NSCLC)' Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. vol 25, No. 18S (June 20 Supplement), 2007: 7554. (5) http://www.who.int/uv/faq/skincancer/en/index1.html (Date of access: May 6, 2008). (6) http...

Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency

...educed-intensity autologous stem cell transplantation in elderly patients with multiple myeloma: Results of a randomised IFM trial. The Lancet vol 370 October 6, 2007, pp 1209-1217 Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-lo...

AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer

... double-blind randomized phase II trial. Journal of Clinical Oncology, vol 24, No 18S, 2006: 7000. (2) Heymach JV et al. Randomized, Placebo-Controll...ously Treated Non-Small-Cell Lung Cancer Journal of Clinical Oncology, vol 25, No 27, 2007: 4270-4277. ...

Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks

...r haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)." The Lancet, vol 370, Pages 1415-1421. October 20, 2007 ...

Mircera Effective in Stabilising Haemoglobin Levels in Elderly Patients With Kidney Disease on Dialysis

...e Unites States Renal Data System 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. American Journal of Kidney Diseases. vol 45, No 1, Suppl 1, January 2005 (iv) European Best Practice Guidelines (v) United States Renal Data System, 2006 (vi) Obrador et al.,...

Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference

...uidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia," Am J Respir Crit Care Med, vol 171. pp. 388-416, 2005.) How often does it occur? According to the American Thoracic Society, the incidence of hospital acquired pneumonia is usua...

New Data Suggests Less Abuse-Related Effects For OROS Methylphenidate

...ce and Correlates of Adult ADHD in the United States: Results from the National Comorbidity Survey Replication." American Journal of Psychiatry. 2006. vol 163. Pg 724-732. CONTACT: On-Site Media Contacts, Ambre Morley of McNeil Pediatrics,Office, +1-609-730-3429, Cell, +1-908-507-0160, Christina Witz o...

New Data Focuses on Abuse of Stimulant Medication

...ce and Correlates of Adult ADHD in the United States: Results from the National Comorbidity Survey Replication." American Journal of Psychiatry. 2006. vol 163. Pg 724-732. ### Yael Goldberg DeVries Public Relations 30 East 60th Street New York, NY 10022 (P) 212.891.0456 (F) 212.644.0291 <...

Cogane Data Presented at ‘11th International Congress of Parkinson’s Disease and Disorders’

...administered orally to pre-clinical models of Parkinson's disease, Cogane(tm) reverses the loss of dopaminergic neurones. *Movement Disorders (2007) vol 22 (Suppl 16): page S18, abstract number 58. Parkinson's disease Parkinson's disease is a movement disorder characterised by muscle rigidity, trem...

New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

...g information or statements. 1. Samama.New England Journal of Medicine.Sept.1999. 2. Bergqvist New England Journal of Medicine March 2002/ vol 346, No.13. 3. Hull, Ann Intern Med.2001; 135:858-869. 4. Geerts.Chest.2004. CONTACT: Contact: Philippe BARQUET +33-6-70-48-61-28 Tick...
Other Tags
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research ... announced the addition of the "Global Facial ... http://photos.prnewswire.com/prnh/20130307/600769 ... the identification of individuals. Facial recognition system measures ... as nose, jaw edges, mouth, and the distance ...
(Date:12/10/2014)... YORK , Dec. 8, 2014 You,ve been ... banking account but can,t remember your password, site key or ... Who was your first grade teacher? Today, ... the app that will finally put an end ... – 1U TM . 1U leverages a user,s ...
(Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
(Date:12/17/2014)... Myo Nwe is the co-author of a new weight loss ... of the Ace Medical Weight Loss Center in Rock Hill, ... at the industry of weight loss, and how several fad ... in television shows, however, she says the topic of obesity ... for basic laughs, which she believes impacts whether Americans view ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 This ... private practices that have made outstanding and innovative ... support and progression of private practice physical therapy ... Physical Therapy Association. , On behalf of Performance ... owner and CEO of Performance accepted the award ...
(Date:12/17/2014)... A group of 127 scientists sent an “open letter” ... a recent statement by the center that was highly critical ... efficacy of all brain exercises. , Signatories to the open ... center’s statement critical of brain exercise companies that overstate their ... case, in a document it had entitled “A Consensus on ...
(Date:12/17/2014)... No matter how far modern medicine ... the head louse parasite—a common childhood malady and a ... between six and twelve million individuals will suffer an ... treatment company comes to the rescue, providing an all-natural ... its track record of customer service, and effectiveness in ...
(Date:12/17/2014)... 2014 Project Veritas is releasing a ... of MIT economist and Obamacare architect Jonathan Gruber to ... conducted the interview, which is being distributed on YouTube. ... intentional mislabeling in the Affordable Care Act in order ... two-hundred-and-fifty billion dollar per year tax grab. , “President ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2
Other Contents